Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Selling, General & Administrative (2010 - 2026)

Analysis

Repligen (RGEN) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 2.33 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 2.07 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 475.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 273.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 278.58 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 113.17 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 212.00 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 76.62 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 78.66 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 238.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.62 Mn
Mar 31, 2026 76.54 Mn
Dec 31, 2025 74.36 Mn
Sep 30, 2025 73.66 Mn
Jun 30, 2025 70.91 Mn
Mar 31, 2025 70.71 Mn
Dec 31, 2024 60.47 Mn
Sep 30, 2024 75.61 Mn
Jun 30, 2024 65.48 Mn
Mar 31, 2024 61.80 Mn
Dec 31, 2023 57.63 Mn
Sep 30, 2023 55.58 Mn
Jun 30, 2023 49.08 Mn
Mar 31, 2023 56.29 Mn
Dec 31, 2022 53.24 Mn
Sep 30, 2022 53.64 Mn
Jun 30, 2022 54.65 Mn
Mar 31, 2022 54.30 Mn
Dec 31, 2021 52.06 Mn
Sep 30, 2021 48.37 Mn